Author:
Siddiqui Maria Fareed,Rasheed Mehreen,Shahid Imran,Tanvir Imrana,Khalid Sidra
Abstract
Hypertension is one of the most important risk factors for morbidity and mortality around the world. Many drugs used to treat hypertension have several side effects. Atenolol used to control hypertension, is an anti-beta-adrenergic agent. It has found to significantly affect the hepatic functions. Objective: To study the effects of atenolol on hepatic dysfunction by measuring AST level in hypertensive patients, taking atenolol alone or in combination with other anti-hypertensive drugs. Methods: The variation in AST level was measured upon use of atenolol alone or in combination with other anti-hypertensive drugs. Out of total 80 patients, 43 were treated with atenolol alone, 37 with atenolol in combination with other anti-hypertensive drugs and 20 were healthy controls. Micro lab tests were used for measurement of AST level. Results: Significant results were found as atenolol cause increase in AST level. Other anti-hypertensive drugs did not affect the AST levels much and the increase in AST level was more significant in patients taking atenolol alone. Conclusions: Atenolol may have efficacy in controlling hypertension, but it causes disturbance in AST levels therefore any other drug in combination with atenolol is recommended to avoid AST variation and eventually hepatic dysfunctions. Further this study may be employed on large scale for strengthening the outcomes of this study
Publisher
CrossLinks International Publishers
Reference21 articles.
1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003 May; 289(19): 2560-71. doi: 10.1001/jama.289.19.2560.
2. Havlik RJ, Garrison RJ, Feinleib M, Kannel WB, Castelli WP, Mcnamara PM. Blood pressure aggregation in families. American Journal of Epidemiology. 1979 Sep; 110(3): 304-12. doi: 10.1093/oxfordjournals.aje.a112815.
3. Hamet P, Pausova Z, Adarichev V, Adaricheva K, Tremblay J. Hypertension: genes and environment. Journal of Hypertension. 1998 Apr; 16(4): 397-418. doi: 10.1097/00004872-199816040-00001.
4. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. New England Journal of Medicine. 1993 Feb; 328(5): 303-7. doi: 10.1056/NEJM199302043280502.
5. Mark AL. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. Journal of hypertension. Supplement: official Journal of the International Society of Hypertension. 1996 Dec; 14(5): S159-65.